Authors:
KRAMER MS
CUTLER N
FEIGHNER J
SHRIVASTAVA R
CARMAN J
SRAMEK JJ
REINES SA
LIU GH
SNAVELY D
WYATTKNOWLES E
HALE JJ
MILLS SG
MACCOSS M
SWAIN CJ
HARRISON T
HILL RG
HEFTI F
SCOLNICK EM
CASCIERI MA
CHICCHI GG
SADOWSKI S
WILLIAMS AR
HEWSON L
SMITH D
CARLSON EJ
HARGREAVES RJ
RUPNIAK NMJ
Citation: Ms. Kramer et al., DISTINCT MECHANISM FOR ANTIDEPRESSANT ACTIVITY BY BLOCKADE OF CENTRALSUBSTANCE-P RECEPTORS, Science, 281(5383), 1998, pp. 1640-1645
Authors:
HALE JJ
MILLS SG
MACCOSS M
FINKE PE
CASCIERI MA
SADOWSKI S
BER E
CHICCHI GG
KURTZ M
METZGER J
EIERMANN G
TSOU NN
TATTERSALL FD
RUPNIAK NMJ
WILLIAMS AR
RYCROFT W
HARGREAVES R
MACINTYRE DE
Citation: Jj. Hale et al., STRUCTURAL OPTIMIZATION AFFORDING ENYL-4-(3-OXO-1,2,4-TRIAZOL-5-YL)METHYLMORPHOLINE, A POTENT, ORALLY-ACTIVE, LONG-ACTING MORPHOLINE ACETALHUMAN NK-1 RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 41(23), 1998, pp. 4607-4614
Authors:
RUPNIAK NMJ
TATTERSALL FD
WILLIAMS AR
RYCROFT W
CARLSON EJ
CASCIERI MA
SADOWSKI S
BER E
HALE JJ
MILLS SG
MACCOSS M
SEWARD E
HUSCROFT I
OWEN S
SWAIN CJ
HILL RG
HARGREAVES RJ
Citation: Nmj. Rupniak et al., IN-VITRO AND IN-VIVO PREDICTORS OF THE ANTIEMETIC ACTIVITY OF TACHYKININ NK1 RECEPTOR ANTAGONISTS, European journal of pharmacology, 326(2-3), 1997, pp. 201-209
Authors:
CASCIERI MA
BER E
FONG TM
HALE JJ
TANG F
SHIAO LL
MILLS SG
MACCOSS M
SADOWSKI S
TOTA MR
STRADER CD
Citation: Ma. Cascieri et al., CHARACTERIZATION OF THE BINDING AND ACTIVITY OF A HIGH-AFFINITY, PSEUDOIRREVERSIBLE MORPHOLINO TACHYKININ NK1 RECEPTOR ANTAGONIST, European journal of pharmacology, 325(2-3), 1997, pp. 253-261
Authors:
RUPNIAK NMJ
TATTERSALL FD
WILLIAMS AR
RYCROFT W
CARLSON EJ
CASCIERI MA
HALE JJ
MILLS SG
MACCOSS M
SEWARD E
HUSCROFT I
SWAIN CJ
HILL RG
HARGREAVES RJ
Citation: Nmj. Rupniak et al., PREDICTION OF THE ANTIEMETIC ACTIVITY OF NK1 RECEPTOR ANTAGONISTS IN FERRETS BY THEIR ABILITY TO INHIBIT GR73632-INDUCED FOOT TAPPING IN GERBILS, British Journal of Pharmacology, 120, 1997, pp. 363-363
Authors:
CALDWELL CG
SAHOO SP
POLO SA
EVERSOLE RR
LANZA TJ
MILLS SG
NIEDZWIECKI LM
IZQUIERDOMARTIN M
CHANG BC
HARRISON RK
KUO DW
LIN TY
STEIN RL
DURETTE PL
HAGMANN WK
Citation: Cg. Caldwell et al., PHOSPHINIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES, Bioorganic & medicinal chemistry letters, 6(3), 1996, pp. 323-328
Authors:
HALE JJ
MILLS SG
MACCOSS M
SHAH SK
QI HB
MATHRE DJ
CASCIERI MA
SADOWSKI S
STRADER CD
MACINTYRE DE
METZGER JM
Citation: Jj. Hale et al., NYL-4-((3-OXO-1,2,4-TRIAZOL-5-YL)METHYL)MORPHOLINE .1. A POTENT, ORALLY-ACTIVE, MORPHOLINE-BASED HUMAN NEUROKININ-1 RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 39(9), 1996, pp. 1760-1762
Authors:
MILLS SG
MACCOSS M
CASCIERI MA
SADOWSKI S
PATEL S
CHAPMAN KL
HUTSON PH
Citation: Sg. Mills et al., 1,2,4-TRIACYLPIPERIDINE SUBSTANCE-P ANTAGONISTS - SEPARATION OF AFFINITIES FOR THE NK-1 RECEPTOR AND THE L-TYPE CALCIUM-CHANNEL, Bioorganic & medicinal chemistry letters, 5(6), 1995, pp. 599-604
Authors:
MILLS SG
MACCOSS M
UNDERWOOD D
SHAH SK
FINKE PE
MILLER DJ
BUDHU RJ
CASCIERI MA
SADOWSKI S
STRADER CD
Citation: Sg. Mills et al., 1,2,3-TRISUBSTITUTED CYCLOHEXYL SUBSTANCE-P ANTAGONISTS - SIGNIFICANCE OF THE RING NITROGEN IN PIPERIDINE-BASED NK-1 RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 5(13), 1995, pp. 1345-1350
Authors:
CASCIERI MA
SHIAO LL
MILLS SG
MACCOSS M
SWAIN CJ
YU H
BER E
SADOWSKI S
WU MT
STRADER CD
FONG TM
Citation: Ma. Cascieri et al., CHARACTERIZATION OF THE INTERACTION OF DIACYLPIPERAZINE ANTAGONISTS WITH THE HUMAN NEUROKININ-1 RECEPTOR - IDENTIFICATION OF A COMMON BINDING-SITE FOR STRUCTURALLY DISSIMILAR ANTAGONISTS, Molecular pharmacology, 47(4), 1995, pp. 660-665